What this CTMS screenshot shows
This public interface reference displays the monitoring visit authoring workflow within Veeva Vault CTMS, specifically focusing on the "Co-Monitoring Visit: Co-Monitoring Visit 3" record which is currently marked as "In Progress". The interface provides clinical monitors with a structured, digital checklist to document site compliance and administrative reviews during a clinical trial monitoring visit. The main workspace displays the "Site Admin and Reg Binder Review" section, where users can answer standardized questions using radio buttons, add comments, and track review status. A comprehensive left-hand navigation panel allows monitors to jump between different sections of the monitoring event, such as subject data, enrollment metrics, and follow-up items. This centralized layout helps clinical operations teams systematically record site activities, track open issues, and maintain regulatory oversight in a single, unified system.
Visible interface elements
- Co-Monitoring Visit: Co-Monitoring Visit 3 title with an In Progress status badge.
- Left-hand navigation panel listing sections like Site Admin and Reg Binder Review and Open Issues (11).
- Site Admin and Reg Binder Review questionnaire containing numbered compliance questions.
- Radio button options for Yes, No, and N/A next to each active question.
- Text input boxes under the Comment column for entering qualitative notes.
- A grayed-out conditional question (3.1) indicating dependency on Question 3.
- Collapsible section headers for Subject Visit SDV and Investigational Medicinal Product Review.
- Top navigation bar with menus including Site Monitoring, Oversight, and Reports.
Interface details
The user interface is divided into a top navigation bar, a left-hand navigation panel, and a central workspace. The top navigation bar includes standard Veeva Vault Clinical menus such as Study Management, Site Monitoring, and Reports, alongside a search bar and user profile controls. The left-hand panel lists various sections of the monitoring visit report, with numbers indicating the count of records or items within each category, such as "Open Issues (11)" and "Subject Data (33)". The active section, "Site Admin and Reg Binder Review", is highlighted. In the central workspace, this section is expanded to show a structured questionnaire. Each question includes radio buttons for "Yes", "No", and "N/A" responses, a text field for comments, and a review status icon. Question 3.1 is conditionally formatted and grayed out, displaying a message that it is dependent on the response to Question 3. Other collapsible sections, such as "Subject Visit SDV" and "Investigational Medicinal Product Review", are visible above and below the active questionnaire, allowing users to expand or collapse content as needed.
Workflow context
In clinical trial management, monitoring visits are critical for ensuring protocol compliance, subject safety, and data integrity at investigational sites. This interface supports the monitoring visit authoring workflow, enabling clinical research associates to document their findings directly within the CTMS. By utilizing structured questionnaires for site administration and regulatory binder reviews, the system standardizes the monitoring process across different sites and studies. The workflow integrates various aspects of site oversight, including the tracking of open issues, follow-up items, and subject data verification. As the monitor completes each section of the checklist, the progress is saved under the "In Progress" status. Once all sections, including investigational product reviews and personnel assessments, are completed, the report can be submitted for review and approval, establishing a clear audit trail of site monitoring activities.
Source, version, and interpretation limits
The analyzed image is a screenshot from the "CTMS Oversight Deep Dive Demo", an official Veeva YouTube video published in March 2022. The screenshot displays a demo tenant with browser chrome visible, indicating a simulated environment. Because this represents a configured demonstration environment, the specific fields, labels, navigation options, and question text may vary based on individual customer configurations, study protocols, and subsequent software updates. The data shown, including the specific questions, counts, and visit names, is synthetic demonstration data and does not represent actual clinical trial results or active regulatory submissions.
Authoritative references
Use these primary sources to confirm current product positioning, terminology, and release-specific behavior.
- CTMS Oversight Deep Dive Demo(Official Veeva YouTube demo)
- Veeva CTMS product overview(Official Veeva product page)
- Veeva CTMS trial-management overview(Official Veeva resource)
